Global Nuclear Medicine Equipment Market Size Study & Forecast, by Product Type (SPECT, PET, Planar Scintigraphy) and Application (Cardiology, Oncology, Neurology, General Imaging) and Regional Forecasts 2025-2035

Description

The Global Nuclear Medicine Equipment Market is valued at approximately USD 2.76 billion in 2024 and is projected to expand at a robust CAGR of 6.70% over the forecast period from 2025 to 2035. Nuclear medicine equipment, encompassing modalities such as Single Photon-Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and Planar Scintigraphy, plays a pivotal role in diagnostic imaging by providing high-precision insights into physiological and biochemical processes. These systems are indispensable for accurate diagnosis, treatment monitoring, and therapeutic planning across multiple clinical domains, including cardiology, oncology, and neurology. The market's growth is propelled by increasing prevalence of chronic and lifestyle-related diseases, rising demand for early and precise diagnostic tools, and continuous technological innovations in imaging modalities.

The surging adoption of advanced nuclear medicine systems is driven by healthcare providers' pursuit of improved patient outcomes and operational efficiency. PET and SPECT imaging technologies, in particular, are witnessing heightened utilization due to their unparalleled ability to visualize molecular and functional changes before structural anomalies occur. According to the World Health Organization, cardiovascular diseases and cancer remain the leading causes of morbidity globally, emphasizing the necessity for advanced diagnostic imaging solutions. Furthermore, research and development investments in radiopharmaceuticals, hybrid imaging systems, and AI-assisted imaging analytics are opening new avenues for enhanced diagnostic accuracy. Nevertheless, challenges such as high equipment costs, stringent regulatory approvals, and limited access in developing regions may moderately restrain market growth during the forecast period.

Regionally, North America commands the largest share of the Nuclear Medicine Equipment Market, underpinned by its well-established healthcare infrastructure, widespread adoption of cutting-edge imaging technologies, and substantial investment in clinical research and diagnostic imaging. Europe holds a significant market presence owing to government initiatives supporting cancer and cardiovascular disease management, as well as strong reimbursement frameworks. The Asia Pacific region is anticipated to register the fastest growth trajectory, fueled by rising healthcare expenditure, burgeoning geriatric populations, expanding hospital networks, and increasing penetration of nuclear medicine technologies in countries like China and India. Latin America and the Middle East & Africa are projected to demonstrate steady growth, driven by infrastructural development, increased awareness of nuclear diagnostic procedures, and gradual expansion of healthcare access.

Major market players included in this report are:

GE Healthcare
Siemens Healthineers
Canon Medical Systems Corporation
Philips Healthcare
Toshiba Medical Systems Corporation
Spectrum Dynamics Medical
Mediso Medical Imaging Systems
Hermes Medical Solutions
Hyperfine Research
Positron Corporation
Sedecal
Cardinal Health
Neusoft Medical Systems
ACIST Medical Systems
PMI Medical Imaging

Global Nuclear Medicine Equipment Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Product Type:

Single Photon-Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)
Planar Scintigraphy

By Application:

Cardiology
Oncology
Neurology
General Imaging
Others

By End User:

Hospitals
Imaging Centers
Academic and Research Centers
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Nuclear Medicine Equipment Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Nuclear Medicine Equipment Market Forces Analysis

3.1. Market Forces Shaping The Global Nuclear Medicine Equipment Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising prevalence of cardiovascular diseases & cancer driving adoption of PET and SPECT imaging
- 3.2.2. Technological advancements (hybrid PET/CT, PET/MRI, CZT-SPECT, AI-assisted image reconstruction & analytics)
3.3. Restraints
- 3.3.1. High capital & maintenance costs and reimbursement variability
- 3.3.2. Regulatory hurdles, isotope supply constraints (e.g., Mo-99/Tc-99m), and shortage of skilled professionals
3.4. Opportunities
- 3.4.1. Growing demand in Asia Pacific with expanding hospital networks and aging populations
- 3.4.2. Radiopharmaceutical innovation & theranostics fueling procedure volumes and new clinical applications

Chapter 4. Global Nuclear Medicine Equipment Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Nuclear Medicine Equipment Market Size & Forecasts by Product Type 2025-2035

5.1. Market Overview
5.2. Global Nuclear Medicine Equipment Market Performance - Potential Analysis (2025)
5.3. Single Photon-Emission Computed Tomography (SPECT)
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Positron Emission Tomography (PET)
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Planar Scintigraphy
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Nuclear Medicine Equipment Market Size & Forecasts by Application 2025-2035

6.1. Market Overview
6.2. Global Nuclear Medicine Equipment Market Performance - Potential Analysis (2025)
6.3. Cardiology
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Oncology
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Neurology
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035
6.6. General Imaging
- 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.6.2. Market size analysis, by region, 2025-2035
6.7. Others
- 6.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.7.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Nuclear Medicine Equipment Market Size & Forecasts by Region 2025-2035

7.1. Nuclear Medicine Equipment Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Nuclear Medicine Equipment Market
- 7.3.1. U.S. Nuclear Medicine Equipment Market
  - 7.3.1.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.3.1.2. Application breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Nuclear Medicine Equipment Market
  - 7.3.2.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.3.2.2. Application breakdown size & forecasts, 2025-2035
7.4. Europe Nuclear Medicine Equipment Market
- 7.4.1. UK Nuclear Medicine Equipment Market
  - 7.4.1.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.4.1.2. Application breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Nuclear Medicine Equipment Market
  - 7.4.2.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.4.2.2. Application breakdown size & forecasts, 2025-2035
- 7.4.3. France Nuclear Medicine Equipment Market
  - 7.4.3.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.4.3.2. Application breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Nuclear Medicine Equipment Market
  - 7.4.4.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.4.4.2. Application breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Nuclear Medicine Equipment Market
  - 7.4.5.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.4.5.2. Application breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Nuclear Medicine Equipment Market
  - 7.4.6.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.4.6.2. Application breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Nuclear Medicine Equipment Market
- 7.5.1. China Nuclear Medicine Equipment Market
  - 7.5.1.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.5.1.2. Application breakdown size & forecasts, 2025-2035
- 7.5.2. India Nuclear Medicine Equipment Market
  - 7.5.2.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.5.2.2. Application breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Nuclear Medicine Equipment Market
  - 7.5.3.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.5.3.2. Application breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Nuclear Medicine Equipment Market
  - 7.5.4.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.5.4.2. Application breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Nuclear Medicine Equipment Market
  - 7.5.5.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.5.5.2. Application breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Nuclear Medicine Equipment Market
  - 7.5.6.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.5.6.2. Application breakdown size & forecasts, 2025-2035
7.6. Latin America Nuclear Medicine Equipment Market
- 7.6.1. Brazil Nuclear Medicine Equipment Market
  - 7.6.1.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.6.1.2. Application breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Nuclear Medicine Equipment Market
  - 7.6.2.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.6.2.2. Application breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Nuclear Medicine Equipment Market
- 7.7.1. UAE Nuclear Medicine Equipment Market
  - 7.7.1.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.7.1.2. Application breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Nuclear Medicine Equipment Market
  - 7.7.2.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.7.2.2. Application breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Nuclear Medicine Equipment Market
  - 7.7.3.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.7.3.2. Application breakdown size & forecasts, 2025-2035
- 7.7.4. Rest of Middle East & Africa Nuclear Medicine Equipment Market
  - 7.7.4.1. Product Type breakdown size & forecasts, 2025-2035
  - 7.7.4.2. Application breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. GE Healthcare
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Siemens Healthineers
8.4. Canon Medical Systems Corporation
8.5. Philips Healthcare
8.6. Toshiba Medical Systems Corporation
8.7. Spectrum Dynamics Medical
8.8. Mediso Medical Imaging Systems
8.9. Hermes Medical Solutions
8.10. Hyperfine Research
8.11. Positron Corporation
8.12. Sedecal
8.13. Cardinal Health
8.14. Neusoft Medical Systems
8.15. ACIST Medical Systems
8.16. PMI Medical Imaging